Martin Mattingly
Director/Board Member presso TRACON PHARMACEUTICALS, INC.
Patrimonio netto: 341 $ in data 31/03/2024
Posizioni attive di Martin Mattingly
Società | Posizione | Inizio | Fine |
---|---|---|---|
TRACON PHARMACEUTICALS, INC. | Director/Board Member | 26/12/2014 | - |
Independent Dir/Board Member | 26/12/2014 | - |
Storia della carriera di Martin Mattingly
Precedenti posizioni note di Martin Mattingly
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACHIEVE LIFE SCIENCES, INC. | Director/Board Member | 01/06/2010 | 07/06/2023 |
Independent Dir/Board Member | 01/06/2010 | 07/06/2023 | |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Director/Board Member | 01/06/2010 | 03/08/2017 |
Independent Dir/Board Member | 01/06/2010 | 03/08/2017 | |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Director/Board Member | 14/11/2007 | 01/11/2011 |
Chief Executive Officer | 14/11/2007 | 01/01/2012 | |
President | 14/11/2007 | 01/01/2012 | |
AMBRX INC | Chief Executive Officer | 20/09/2005 | 01/09/2007 |
President | 20/09/2005 | 01/09/2007 | |
CancerVax Corp. | Chief Operating Officer | 01/06/2005 | 01/09/2005 |
Corporate Officer/Principal | 01/05/2003 | 01/06/2005 | |
PFIZER, INC. | Sales & Marketing | 01/01/1996 | 01/01/2003 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/1996 | 01/01/2003 |
Tech Coast Angels, Inc.
Tech Coast Angels, Inc. Investment ManagersFinance Tech Coast Angels, Inc. (Tech Coast Angels) is an angel firm founded in 1997 by Luis Villalobos. The firm is headquartered in Irvine, California. | Corporate Officer/Principal | - | - |
Formazione di Martin Mattingly
University of Kentucky | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Canada | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Settori
Health Technology | 8 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
PFIZER, INC. | Health Technology |
TRACON PHARMACEUTICALS, INC. | Health Technology |
ACHIEVE LIFE SCIENCES, INC. | Health Technology |
Aziende private | 6 |
---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
CancerVax Corp. | Commercial Services |
Ambrx, Inc.
Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Tech Coast Angels, Inc.
Tech Coast Angels, Inc. Investment ManagersFinance Tech Coast Angels, Inc. (Tech Coast Angels) is an angel firm founded in 1997 by Luis Villalobos. The firm is headquartered in Irvine, California. | Finance |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Martin Mattingly
- Esperienza